Zynerba Pharmaceuticals Inc.
ZYNE
|
|
| |
|
| Trading Volume | 862,786 |
|
|
1.39 - 1.21 |
| Market Cap Full | $ 70.1M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | - | -18.9% | -32.3% |
| Q2 | - | - | -24.2% | -43.7% |
| Q3 | - | - | 289.6% | -35.8% |
| Q4 | - | - | 2.4% | -27.6% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| 26.4 | -31 | -6.9 | -10.7 | -13 | -2.4 | 12 | 264.4 | -4.5 | 2.4 | - | - |
| 2022 | |||||||||||
| -13.2 | -12.9 | -10.4 | -30.4 | -32.1 | 19.1 | - | 2.6 | -37.4 | -0.3 | -26.4 | -1.3 |
| 2021 | |||||||||||
| 5.8 | 28.8 | 3.5 | -5.2 | 28.8 | -6.9 | -16.6 | 0.5 | -4.3 | -9.7 | -9.7 | -13.6 |
| 2020 | |||||||||||
| -14.8 | -10.8 | -12.4 | 1 | 35.9 | -35.9 | 11.3 | 0.8 | -12.4 | 2.1 | 37.3 | -28.9 |
EPS
| 2022 | 2021 | 2020 | |
|---|---|---|---|
| Q1 | -0.2 | -0.2 | -0.5 |
| Q2 | -0.2 | -0.3 | -0.8 |
| Q3 | -0.2 | -0.3 | -0.3 |
| Q4 | -0.2 | -0.2 | -0.3 |
| A | -0.8 | -1 | -1.9 |